Effects of low dose computed tomography (LDCT) on lung cancer screening on incidence and mortality in regions with high tuberculosis prevalence: A systematic review

PLoS One. 2024 Sep 11;19(9):e0308106. doi: 10.1371/journal.pone.0308106. eCollection 2024.

Abstract

Background: Lung cancer screening (LCS) using low-dose computed tomography (LDCT) is a strategy for early-stage diagnosis. The implementation of LDCT screening in countries with a high prevalence/incidence of tuberculosis (TB) is controversial. This systematic review and meta-analysis aim to identify whether LCS using LDCT increases early-stage diagnosis and decreases mortality, as well as the false-positive rate, in regions with a high prevalence of TB.

Methods/design: Studies were identified by searching BVS, PUBMED, EMBASE, and SCOPUS. RCT and cohort studies (CS) that show the effects of LDCT in LC screening on mortality and secondary outcomes were eligible. Two independent reviewers evaluated eligibility and a third judged disagreements. We used the Systematic Review Data Repository (SRDR+) to extract the metadata and record decisions. The analyses were stratified by study design and incidence of TB. We used the Cochrane "Risk of bias" assessment tool.

Results: The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) were used. Thirty-seven papers were included, referring to 22 studies (10 RCTs and 12 cohorts). Few studies were from regions with a high incidence of TB (One RCT and four cohorts). Nonetheless, the evidence is compatible with European and USA studies. RCTs and CS also had consistent results. There is an increase in early-stage (I-II) diagnoses and reduced LC mortality in the LCDT arm compared to the control. Although false-positive rates varied, they stayed within the 20 to 30% range.

Discussion: This is the first meta-analysis of LDCT for LCS focused on its benefits in regions with an increased incidence/prevalence of TB. Although the specificity of Lung-RADS was higher in participants without TB sequelae than in those with TB sequelae, our findings point out that the difference does not invalidate implementing LDCT LCS in these regions.

Trial registration: Systematic review registration Systematic review registration PROSPERO CRD42022309581.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • Early Detection of Cancer* / methods
  • Early Detection of Cancer* / statistics & numerical data
  • Humans
  • Incidence
  • Lung Neoplasms* / diagnostic imaging
  • Lung Neoplasms* / epidemiology
  • Mass Screening / methods
  • Mass Screening / organization & administration
  • Mass Screening / statistics & numerical data
  • Prevalence
  • Tomography, X-Ray Computed* / methods
  • Tomography, X-Ray Computed* / statistics & numerical data
  • Tuberculosis / diagnostic imaging
  • Tuberculosis / epidemiology

Grants and funding

This research was funded partially by departmental funds of the Division of Thoracic Surgery Department of Surgery - UMass Chan Medical School, Worcester – MA. Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro Grant Number: E-26/ 210.131/2022. Oswaldo Cruz Foundation – Fiocruz Brazil – INOVA Grant Number: VPPCB-007-FIO-18-2-128. The funding agencies did NOT have any role in the design and conduct of the study, collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.